Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Toxicokinetics: Overview01:21

Toxicokinetics: Overview

Studies that assess how a drug is absorbed, distributed, metabolized, and excreted (ADME) at toxic doses are termed toxicokinetics. Understanding toxicokinetics helps predict adverse drug reactions (ADRs) and manage toxicity in humans.Toxicokinetics differs from pharmacokinetics mainly in the dose levels studied, with toxicokinetics focusing on higher toxic doses. The kinetics at these levels can be non-linear due to altered physiological processes. Toxicodynamics examines the relationship...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Drug Toxicity: Overview01:00

Drug Toxicity: Overview

Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Progressive renal light chain amyloidosis with the absence of detectable free monoclonal light chains after an autologous hematopoietic stem cell transplant for amyloid light chain amyloidosis.

Archives of pathology & laboratory medicine·2013
Same author

Toxicology testing in alternative specimen matrices.

Clinics in laboratory medicine·2012
Same author

Regulatory issues in accreditation of toxicology laboratories.

Clinics in laboratory medicine·2012
Same author

Toxicology testing.

Clinics in laboratory medicine·2012
Same author

Studying critical values: adverse event identification following a critical laboratory values study at the ohio state university medical center.

American journal of clinical pathology·2007
Same author

Beware of unwritten institutional policies.

Clinical leadership & management review : the journal of CLMA·2007

Related Experiment Video

Updated: May 19, 2026

Assessment of Chemical Toxicity in Adult Drosophila Melanogaster
07:02

Assessment of Chemical Toxicity in Adult Drosophila Melanogaster

Published on: March 24, 2023

Overview of progress in clinical toxicology testing.

Donald L Frederick1, Michael G Bissell

  • 1Pathology Department, Peoria Tazewell Pathology Group, 221 NE Glen Oak Avenue, Peoria, IL 61636, USA.

Clinics in Laboratory Medicine
|September 4, 2012
PubMed
Summary

This study explores the historical development of clinical toxicology services. It reviews how clinical laboratories have evolved in diagnosing and managing human poisonings. The authors highlight key changes in diagnostic methods and treatment approaches over time. They emphasize the importance of understanding historical context in current practices. The study does not claim that all advancements are essential but notes their significance. The findings suggest that continued development in clinical toxicology is necessary. The authors propose that future research should build on this historical foundation. This work provides a structured overview of the field's progression.

Keywords:
clinical toxicologydiagnostic methodslaboratory servicesmedical poisoning management

Frequently Asked Questions

More Related Videos

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
17:28

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation

Published on: June 17, 2015

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)
11:38

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)

Published on: May 10, 2016

Related Experiment Videos

Last Updated: May 19, 2026

Assessment of Chemical Toxicity in Adult Drosophila Melanogaster
07:02

Assessment of Chemical Toxicity in Adult Drosophila Melanogaster

Published on: March 24, 2023

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
17:28

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation

Published on: June 17, 2015

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)
11:38

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)

Published on: May 10, 2016

Area of Science:

  • Clinical toxicology diagnostics
  • Clinical laboratory science
  • Medical toxicology

Background:

Clinical toxicology involves diagnosing and managing human poisoning cases. Prior research has shown that this field relies on clinical laboratory services. No prior work had resolved the full historical development of these services. This gap motivated a detailed examination of how these services evolved. The role of clinical laboratories in managing poisonings is well established. However, the progression of these services remains underexplored. This paper addresses that uncertainty by focusing on historical development. It aims to clarify the timeline and evolution of clinical toxicology practices.

Purpose Of The Study:

The study aimed to examine the historical development of clinical laboratory services in clinical toxicology. It sought to clarify how these services evolved over time. The specific problem was the lack of detailed historical analysis in the field. This uncertainty drove the need for a focused review. The authors wanted to document the progression of clinical toxicology practices. They aimed to highlight key developments in diagnostic and management approaches. The motivation was to provide a comprehensive overview for practitioners and researchers. This work fills a gap in understanding the field's historical foundations.

Main Methods:

The researchers conducted a review of historical developments in clinical toxicology. They analyzed the evolution of clinical laboratory services over time. The approach included examining documented changes in diagnostic methods. They also considered shifts in treatment and management strategies. The study focused on hospital and clinic settings as primary locations. The authors used a literature-based approach to trace historical patterns. They synthesized evidence from prior studies and clinical reports. This method allowed them to present a structured overview of the field's progression.

Main Results:

The study found that clinical toxicology services have evolved significantly over time. It revealed that diagnostic methods have become more sophisticated. The authors noted improvements in treatment protocols for poisoning cases. They identified key milestones in the development of clinical laboratories. The results suggest that early practices were less standardized. The study showed a shift toward more systematic diagnostic approaches. It also highlighted the growing role of clinical laboratories in management. These findings trace the historical trajectory of the field's development.

Conclusions:

The authors concluded that clinical toxicology has seen notable advancements in laboratory services. They emphasized the importance of historical context in understanding current practices. The study suggests that progress in diagnostics has improved patient outcomes. It also highlights the need for continued development in clinical toxicology. The authors propose that historical insights inform future improvements. They suggest that understanding past developments aids in refining current practices. The study does not claim that all advancements are essential but notes their significance. It proposes that further research should build on this historical foundation.

Clinical toxicology focuses on diagnosing, treating, and managing human poisoning cases.

The field has seen significant changes in diagnostic methods and treatment protocols over time.

Clinical laboratories provide essential services for diagnosing and managing poisoning cases.

These settings are primary locations where clinical toxicology services are practiced.

Treatment protocols have become more systematic and standardized over time.

The authors suggest that understanding historical developments can inform future improvements in clinical toxicology.